GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (A2BUN9)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (A2BUN9) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A2BUN9
Type
protein
Length
423 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xBF0D2e107Ce1EcD2C4369B042274201DB719AaAF
Molecule
Serine hydroxymethyltransferase
UniProt
A2BUN9
Pockets
4 · best druggability 0.54

Structure

1 distinct chain · 47% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein42347% helix, 14% strandA2BUN9

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13120.540.7535empty
21580.460.7631empty
3920.390.7617empty
4530.270.7413empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.